Dimeditiapramine
Dimeditiapramine (Tiapamil) is a calcium channel blocker.[1] Tiapamil has been described as an "antianginal agent".
![]() | |
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name
2-(3,4-Dimethoxyphenyl)-2-(3-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}propyl)-1λ6,3λ6-dithiane-1,1,3,3-tetrone | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.054.992 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| Properties | |
| C26H37NO8S2 | |
| Molar mass | 555.70388 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
See also
References
- Cocco, G.; Strozzi, C.; Chu, D. (1979). "Human electropharmacology of the calcium antagonist dimeditiapramine (Ro 11-1781) in coronary patients". Clinical Cardiology. 2 (3): 212–6. doi:10.1002/clc.4960020307. PMID 509799. S2CID 24609271.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

